American Shared Hospital Services (AMS) AI Stock Analysis

American Shared Hospital Services specializes in leasing radiosurgery and radiation therapy equipment to healthcare providers. The company's offerings include Gamma Knife stereotactic radiosurgery equipment for treating malignant and benign brain tumors, arteriovenous malformations, and trigeminal neuralgia, along with specialized financing options for Leksell Gamma Knife units. It also delivers proton beam radiation therapy services in Orlando, Florida, and Long Beach, California. Beyond equipment leasing, it provides planning, installation, reimbursement guidance, and marketing assistance. Founded in 1980 and based in San Francisco, California, the company operated 115 Gamma Knife units as of December 31, 2021, and has expanded internationally into Lima, Peru, and Guayaquil, Ecuador.

Revenue expanded at a 5-year CAGR of 9.5% from FY2020 to FY2025. Annual revenue rose to $28.3M in FY2024 before decreasing 0.9% to $28.1M in FY2025. Gross margin contracted from 43.8% in FY2023 to 32.4% in FY2024 and 18.0% in FY2025. Net income shifted from $2.2M in FY2024 to -$1.6M in FY2025, with an operating margin of -7.2%. Over the trailing twelve months, revenue reached $30.4M with an EPS of -$0.26. In the latest quarter ended June 30, 2026, revenue increased 19.2% year-over-year, while quarterly earnings declined 38.1%.

As of June 30, 2026, American Shared Hospital Services held $6.5M in cash and short-term investments against $20.5M in total debt, resulting in net debt of $14.0M. The current ratio was 0.77, and debt-to-equity was 0.89 alongside shareholders' equity of $23.1M. During FY2025, operating cash flow was $3.1M while capital expenditures totaled $7.6M, resulting in free cash flow of -$4.5M. The company's share count grew 12.3% over 5 years.

With a market cap of $8.5M and an enterprise value of $25.3M, American Shared Hospital Services trades at a forward P/E of 44.6x, above the 17.3x median of its US-listed Healthcare peers. Its price-to-sales of 0.3x and EV-to-EBITDA of 7.2x trade below peer medians of 4.1x and 12.0x, respectively. Over the past 1 year, the stock fell 43.6% compared to a 16.8% gain for the S&P 500 (SPY), and over 5 years, it fell 54.4% against an 83.0% advance for SPY.

Analysts maintain a mean price target of $4.00, compared to the last close of $1.28 on October 16, 2026. For the current fiscal year ending December 31, 2026, estimates project revenue of $32.7M and an EPS of -$0.14, reflecting an estimated EPS growth of 39.1%. The company delivered 0 EPS beats over the last 4 quarters. The next earnings date is November 12, 2026.

This page is an AI-written research summary of American Shared Hospital Services (AMS). The text was generated on October 30, 2026 from Quotelinks data as of October 16, 2026 (company profile, annual results, latest balance sheet, valuation, price performance and analyst estimates). An automatic check rejects any draft that contains a figure not found in that data. It is not investment advice; verify figures on the linked tabs before making decisions.

Related: AMS income statement, AMS balance sheet, AMS key metrics, AMS analyst forecast, AMS chart. See the AMS stock overview for the latest quote and news.